These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11802749)

  • 1. Cost-effectiveness of a single colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F
    Arch Intern Med; 2002 Jan; 162(2):163-8. PubMed ID: 11802749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat colonoscopy every 10 years or single colonoscopy for colorectal neoplasm screening in average-risk Chinese: a cost-effectiveness analysis.
    Wang ZH; Gao QY; Fang JY
    Asian Pac J Cancer Prev; 2012; 13(5):1761-6. PubMed ID: 22901118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is virtual colonoscopy a cost-effective option to screen for colorectal cancer?
    Sonnenberg A; Delcò F; Bauerfeind P
    Am J Gastroenterol; 1999 Aug; 94(8):2268-74. PubMed ID: 10445561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.
    Hassan C; Zullo A; Winn S; Morini S
    Endoscopy; 2008 May; 40(5):414-21. PubMed ID: 18302080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decision-analytic evaluation of the cost-effectiveness of family history-based colorectal cancer screening programs.
    Ramsey SD; Wilschut J; Boer R; van Ballegooijen M
    Am J Gastroenterol; 2010 Aug; 105(8):1861-9. PubMed ID: 20461066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries.
    Wu GH; Wang YM; Yen AM; Wong JM; Lai HC; Warwick J; Chen TH
    BMC Cancer; 2006 May; 6():136. PubMed ID: 16723013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopist-directed propofol administration versus anesthesiologist assistance for colorectal cancer screening: a cost-effectiveness analysis.
    Hassan C; Rex DK; Cooper GS; Benamouzig R
    Endoscopy; 2012 May; 44(5):456-64. PubMed ID: 22531982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination aspirin and/or calcium chemoprevention with colonoscopy in colorectal cancer prevention: cost-effectiveness analyses.
    Pence BC; Belasco EJ; Lyford CP
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):399-405. PubMed ID: 23250933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
    Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of screening the average-risk population for colorectal cancer.
    Provenzale D
    Gastrointest Endosc Clin N Am; 2002 Jan; 12(1):93-109. PubMed ID: 11916165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis.
    Ladabaum U; Chopra CL; Huang G; Scheiman JM; Chernew ME; Fendrick AM
    Ann Intern Med; 2001 Nov; 135(9):769-81. PubMed ID: 11694102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT colonography to screen for colorectal cancer and aortic aneurysm in the Medicare population: cost-effectiveness analysis.
    Pickhardt PJ; Hassan C; Laghi A; Kim DH
    AJR Am J Roentgenol; 2009 May; 192(5):1332-40. PubMed ID: 19380558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis.
    Ladabaum U; Scheiman JM; Fendrick AM
    Am J Med; 2003 May; 114(7):546-54. PubMed ID: 12753878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.
    Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y
    Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis.
    Hassan C; Rex DK; Cooper GS; Zullo A; Launois R; Benamouzig R
    Gut; 2012 Aug; 61(8):1172-9. PubMed ID: 21997545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis.
    Suleiman S; Rex DK; Sonnenberg A
    Gastroenterology; 2002 Jan; 122(1):78-84. PubMed ID: 11781283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of colonoscopy in screening for colorectal cancer; cost-effectiveness of screening colorectal cancer in the general population.
    Lieberman D
    Gastrointest Endosc; 2001 Oct; 54(4):537-8. PubMed ID: 11601425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.